Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples